An Overview of Transcranial Magnetic Stimulation and Its Application in Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
Transcranial magnetic stimulation (TMS) is a flexible, non-invasive technique that involves the production of a brief magnetic field to stimulate the conductive structures of the brain. When TMS is specifically employed as a single- or paired-pulse over the motor cortex, the function and integrity of the descending motor pathways can be assessed through the generation of a motor evoked potential (MEP). Important MEP-derived measures include the motor threshold, MEP amplitude and latency, central motor conduction time, silent period, intracortical inhibition, and intracortical facilitation. These functional measures may have use in individuals with multiple sclerosis (MS), a common chronic autoimmune disorder of the central nervous system, due to their useful diagnostic and prognostic implications. As a representation of excitability and conductivity, TMS measures may have the potential to serve as objective markers of corticospinal tract integrity, which is a major aspect of clinical disability in MS. Additionally, TMS may be employed to help monitor and provide insight on the effects of therapies for patients with MS over a longitudinal timeframe. In this review, we focus on the application of TMS in the context of MS, with an emphasis on the relationship between TMS measures and widely used clinical assessment measures used for patients with MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In multiple sclerosis (MS), TMS targeting motor, prefrontal, and cerebellar regions demonstrates improvements in spasticity, gait, fatigue, and cognitive function [116,117].”
From The Heart’s Electromagnetic Field in Emotions, Empathy and Human Connection: Biosensor-Derived Insights into Heart–Brain Axis Mechanisms and a Basis for Novel BioMagnetoTherapies (2026) · cites this paper as [116]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009) · Clinical Neurophysiology · doi:10.1016/j.clinph.2009.08.016 · Cited by 5,367 · cited 3×
“Manufacturer guidelines may also require these coils to be maintained regularly [8,10].”
BackgroundRossini, P. M., Burke, D., Chen, R., Cohen, L. G., Daskalakis, Z., Di Iorio, R., Di Lazzaro, V., Ferreri, F., Fitzgerald, P. B., George, M. S., et al. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2015.02.001 · Cited by 2,753 · cited 4×
“It is important consider the potential effects of physiological confounders such as age, height, and sex A paper by Rossini et al. [13] reported that most studies have found no/weak correlation between age and sex with CMCT. on CMCT.”
BackgroundInfluentialRising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520970841 · Cited by 2,653 · cited 2×
“It is estimated that 2.8 million people live with MS across the world, with a global increase in prevalence year after year [3].”
BackgroundInfluentialLefaucheur, J.-P., Aleman, A., Baeken, C., Benninger, D. H., Brunelin, J., Di Lazzaro, V., Filipović, S. R., Grefkes, C., Hasan, A., Hummel, F. C., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.11.002 · Cited by 2,382 · cited 1×
“…was made for “probable efficacy of intermittent theta burst stimulation (iTBS) of the leg area of M1 contralateral to the most affected limb (or both M1) in lower limb spasticity”, as found in the evidence-based guidelines for the therapeutic use of rTMS, established by Lefaucheur et al. [67].”
Rossi, S., Antal, A., Bestmann, S., Bikson, M., Brewer, C., Brockmöller, J., Carpenter, L. L., Cincotta, M., Chen, R., Daskalakis, J. D., et al. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.10.003 · Cited by 1,573 · cited 3×
“Other general factors may include sleep deprivation, stress, anxiety, and medical conditions that can lower one’s seizure threshold [10].”
A practical guide to diagnostic transcranial magnetic stimulation: Report of an IFCN committee
Groppa, S., Oliviero, A., Eisen, A., Quartarone, A., Cohen, L. G., Mall, V., Kaelin-Lang, A., Mima, T., Rossi, S., Thickbroom, G. W., et al. (2012) · Clinical Neurophysiology · doi:10.1016/j.clinph.2012.01.010 · Cited by 1,274 · cited 6×
“Of particular importance is the latency of MEP onset and amplitude, which is measured as the peak-to-peak (maximal positive to maximal negative) difference in voltage [12]. peak-to-peak (maximal positive to maximal negative) difference in voltage [12].”
BackgroundInfluentialDiagnosis and Treatment of Multiple Sclerosis: A Review
McGinley, M. P., Goldschmidt, C. H., & Rae-Grant, A. D. (2021) · JAMA · doi:10.1001/jama.2020.26858 · Cited by 1,205 · cited 3×
“MS typically has a mean onset at 20 to 30 years of age and is more common in females than males, at a ratio of approximately 3:1 [1].”
BackgroundInfluentialBasic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS)
Klomjai, W., Katz, R., & Lackmy-Vallée, A. (2015) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2015.05.005 · Cited by 864 · cited 1×
“Single-or paired-pulse TMS is often used to explore brain and conductive pathway function, while repetitive TMS (rTMS) can be employed to modulate brain activity for therapeutic purposes in neurological conditions such as depression and Parkinson’s disease [4,5].”
BackgroundZiemann, U., Reis, J., Schwenkreis, P., Rosanova, M., Strafella, A., Badawy, R., & Müller-Dahlhaus, F. (2015) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.08.028 · Cited by 681 · cited 2×
“…the excitability of the In the literature, the MT has been described as a representation for the excitability of the corticospinal pathway [12,14,15], and previous studies have reported abnormal MTs in patients with MS [16]. corticospinal pathway [12,14,15], and previous studies have reported…”
ResultMeyer-Moock, S., Feng, Y.-S., Maeurer, M., Dippel, F.-W., & Kohlmann, T. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-58 · Cited by 639
Epidemiology of Multiple Sclerosis
Howard, J., Trevick, S., & Younger, D. S. (2016) · Neurologic Clinics · doi:10.1016/j.ncl.2016.06.016 · Cited by 269 · cited 3×
“Subsequent to this injury, varying degrees of repair and remission follow [36].”
BackgroundInfluentialTranscranial magnetic stimulation
(2019) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-64032-1.00037-0 · Cited by 215
Goldsworthy, M. R., Hordacre, B., & Ridding, M. C. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.012 · Cited by 197
Outcome Measures in Clinical Trials for Multiple Sclerosis
van Munster, C. E. P., & Uitdehaag, B. M. J. (2017) · CNS Drugs · doi:10.1007/s40263-017-0412-5 · Cited by 196
Lerner, A. J., Wassermann, E. M., & Tamir, D. I. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.03.016 · Cited by 168 · cited 1×
“However, the reported frequency is extremely low, with a survey by Lerner et al. suggesting a rate at less than 1 event per 60,000 sessions [9].”
ResultCash, R. F. H., Noda, Y., Zomorrodi, R., Radhu, N., Farzan, F., Rajji, T. K., Fitzgerald, P. B., Chen, R., Daskalakis, Z. J., & Blumberger, D. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.133 · Cited by 167 · cited 2×
“On the other hand, ICF is thought to arise from the summation of excitatory postsynaptic potentials [29].”
BackgroundIngram, D. A., Thompson, A. J., & Swash, M. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.4.487 · Cited by 163 · cited 1×
“Numerous studies [31,38–44, 46, 48–51, 53, 58] have As shown in Table 2, abnormal measures of CMCT in patients with MS are frequently re-ported.”
BackgroundCentral motor conduction: Method and normal results
Claus, D. (1990) · Muscle & Nerve · doi:10.1002/mus.880131207 · Cited by 157 · cited 1×
“A paper by Rossini et al. [13] reported that most studies have found no/weak Regarding height, there appears to be no correlation between height and CMCT for the upper limbs; however, there exists a strong correlation between height and CMCT for the lower limbs [22–24].”
BackgroundLiepert, J., Mingers, D., Heesen, C., Bäumer, T., & Weiller, C. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1163oa · Cited by 154 · cited 1×
“ICI and ICF measures have been found to be abnormal in some MS patients [30–32], as well as those with other neurodegenerative conditions such as Parkinson’s disease [33].”
BackgroundImproving quality of life in multiple sclerosis: an unmet need.
Zwibel, H., & Smrtka, J. (2011) · PubMed · Cited by 150
Increased motor cortical facilitation and decreased inhibition in Parkinson disease
Ni, Z., Bahl, N., Gunraj, C. A., Mazzella, F., & Chen, R. (2013) · Neurology · doi:10.1212/wnl.0b013e3182919029 · Cited by 148 · cited 1×
“ICI and ICF measures have been found to be abnormal in some MS patients [30–32], as well as those with other neurodegenerative conditions such as Parkinson’s disease [33].”
BackgroundMultiple sclerosis: Diagnosis and Differrential Diagnosis
Ömerhoca, S., Akkaş, S. Y., & Icen, N. K. (2018) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.23418 · Cited by 110
Cuypers, K., Thijs, H., & Meesen, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086380 · Cited by 95
Pellegrino, L., Coscia, M., Müller, M., Solaro, C. M., & Casadio, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-20343-y · Cited by 95 · cited 1×
“However, it is important to note that sensorimotor impairments of the lower limb are often prominent in patients with MS, and so they are the primary focus of many studies [37].”
BackgroundŠkarabot, J., Mesquita, R. N. O., Brownstein, C. G., & Ansdell, P. (2019) · Experimental Physiology · doi:10.1113/ep087557 · Cited by 94
Llufriu, S., Blanco, Y., Martinez-Heras, E., Casanova-Molla, J., Gabilondo, I., Sepulveda, M., Falcon, C., Berenguer, J., Bargallo, N., Villoslada, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037167 · Cited by 90
Bastani, A., & Jaberzadeh, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047582 · Cited by 89
Neva, J. L., Lakhani, B., Brown, K. E., Wadden, K. P., Mang, C. S., Ledwell, N. M. H., Borich, M. R., Vavasour, I. M., Laule, C., Traboulsee, A. L., et al. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.10.015 · Cited by 87 · cited 3×
“Llufriu et al. reported iSP onset latency to be longer in patients with MS, and also found a correlation with EDSS and MSFC. Neva et al. [16] did not find that the duration of the SP for MS patients was different compared to the control, but did find that the onset of the SP was delayed.”
BackgroundResultCortical dysfunction underlies disability in multiple sclerosis
Vucic, S., Burke, T. V., Lenton, K., Ramanathan, S., Gomes, L. J., Yiannikas, C., & Kiernan, M. C. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511424308 · Cited by 80 · cited 6×
“Regarding SICI, the same study by Vucic et al. [31] found reduced SICI in SPMS patients, and reported a correlation between SICI and other TMS measures with EDSS.”
BackgroundResultInfluentialConte, A., Lenzi, A., Frasca, V., Gilio, F., Giacomelli, E., Gabriele, M., Bettolo, C. M., Iacovelli, E., Pantano, P., Pozzilli, C., et al. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5047-0 · Cited by 76 · cited 3×
“This is thought to reflect changes in cortical excitability [30].”
BackgroundConduction deficits of callosal fibres in early multiple sclerosis
Schmierer, K. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.5.633 · Cited by 68
Kale, N., Ağaoğlu, J., Onder, G., & Tanik, O. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.03.009 · Cited by 66 · cited 2×
“However, a number of studies have also found decreased MEP amplitudes, prolonged MEP latencies, and increased MT in patients with MS [16,31,40,42–44, 46, 48, 49 , 51 , 54–56].”
BackgroundMotor-evoked potentials in response to fatiguing grip exercise in multiple sclerosis patients
Petajan, J. H., & White, A. T. (2000) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00469-7 · Cited by 63 · cited 1×
“However, a number of studies have also found decreased MEP amplitudes, prolonged MEP latencies, and increased MT in patients with MS [16,31,40,42–44, 46, 48, 49 , 51 , 54–56].”
BackgroundA framework to assess the impact of number of trials on the amplitude of motor evoked potentials
Ammann, C., Guida, P., Caballero‐Insaurriaga, J., Pineda‐Pardo, J. A., Oliviero, A., & Foffani, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-77383-6 · Cited by 56 · cited 1×
“4 of 15 While the MEP amplitude is commonly reported in studies involving TMS, it is also subject to the same factors that influence the MT, leading to high variability between trials [12,18]. neurons and decreasing the threshold required to fire [17].”
BackgroundTranscranial magnetic stimulation (TMS) and repetitive TMS in multiple sclerosis
Aloizou, A., Pateraki, G., Anargyros, K., Siokas, V., Bakirtzis, C., Liampas, I., Νούσια, Α., Nasios, G., Sgantzos, M. N., Peristeri, E., et al. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0140 · Cited by 54 · cited 2×
“However, sample sizes and differences in protocols continue to be challenges in this field [66].”
BackgroundMethodTranscranial brain stimulation: Past and future
Rothwell, J. C. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818818070 · Cited by 53 · cited 2×
“Single-or paired-pulse TMS is often used to explore brain and conductive pathway function, while repetitive TMS (rTMS) can be employed to modulate brain activity for therapeutic purposes in neurological conditions such as depression and Parkinson’s disease [4,5].”
BackgroundAnatomo-Functional Origins of the Cortical Silent Period: Spotlight on the Basal Ganglia
Zeugin, D., & Ionta, S. (2021) · Brain Sciences · doi:10.3390/brainsci11060705 · Cited by 53 · cited 2×
“There is some debate over the mechanisms that contribute to the silent period [26,27].”
BackgroundKidd, D. P. (1998) · Brain · doi:10.1093/brain/121.6.1109 · Cited by 51 · cited 2×
“Kidd et al. [41], in their longitudinal assessment, reported deterioration that was both associated with and independent of changes in CMCT/MRI measures.”
BackgroundMethod[Multiple sclerosis, diagnosis and differential diagnosis].
Mumenthaler, M. S. (1967) · PubMed · Cited by 51
Corticomotor organisation and motor function in multiple sclerosis
Thickbroom, G. W., Byrnes, M. L., Archer, S. A., Kermode, A. G., & Mastaglia, F. L. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0728-9 · Cited by 47
Kalkers, N. F., STRIJERS, R. L. M., Jasperse, B., Neacsu, V., Geurts, J. J. G., Barkhof, F., Polman, C. H., & Stam, C. J. (2007) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.02.018 · Cited by 47 · cited 1×
“A more recent study by Kalkers et al. [50] examined a cohort of 52 MS patients and found that T1-and T2-weighted brain lesion volume and the number of spinal cord lesions had moderate positive correlations with CMCT to all limbs (upper/lower, right/left) and a correlation with EDSS results.”
ResultClinical Value of the Assessment of Changes in MEP Duration with Voluntary Contraction
Brum, M., Cabib, C., & Valls‐Solé, J. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00505 · Cited by 46 · cited 2×
“4 of 15 While the MEP amplitude is commonly reported in studies involving TMS, it is also subject to the same factors that influence the MT, leading to high variability between trials [12,18]. neurons and decreasing the threshold required to fire [17].”
BackgroundMori, F., Kusayanagi, H., Monteleone, F., Moscatelli, A., Nicoletti, C. G., Bernardi, G., & Centonze, D. (2012) · Brain stimulation · doi:10.1016/j.brs.2012.02.001 · Cited by 45 · cited 1×
“However, previous studies have reported mixed results regarding the potential association between disability, ICI, and ICF measures [31,34,35].”
ResultLower Extremity Motor Evoked Potentials in Multiple Sclerosis
Jones, S. M., Streletz, L. J., Raab, V. E., Knobler, R. L., & Lublin, F. D. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530210070026 · Cited by 44
Cortical excitability changes over time in progressive multiple sclerosis
Ayache, S. S. (2015) · Functional Neurology · doi:10.11138/fneur/2015.30.4.257 · Cited by 42
Kandler, R., Jarratt, J. A., Davies-Jones, G. A. B., Gumpert, E. J. W., Venables, G. S., SAGAR, H. J., & Zeman, A. Z. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90190-i · Cited by 41
Simpson, M. A., & Macdonell, R. A. L. (2015) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.06.014 · Cited by 39 · cited 6×
“The motor threshold (MT) is defined as the minimum stimulus intensity capable of evoking MEPs with a given peak-to-peak response in at least 50% of trials [7].”
BackgroundInfluentialGagliardo, A., Galli, F., Grippo, A., Amantini, A., Martinelli, C., Amato, M. P., & Borsini, W. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0334-5 · Cited by 39 · cited 1×
“However, a number of studies have also found decreased MEP amplitudes, prolonged MEP latencies, and increased MT in patients with MS [16,31,40,42–44, 46, 48, 49 , 51 , 54–56].”
BackgroundNantes, J. C., zhong, J., Holmes, S. A., Narayanan, S., Lapierre, Y., & Koski, L. M. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.01.003 · Cited by 39 · cited 1×
“However, previous studies have reported mixed results regarding the potential association between disability, ICI, and ICF measures [31,34,35].”
ResultCortical silent period and motor evoked potentials in patients with multiple sclerosis
Tataroğlu, C., Genç, A., İdıman, E., Çakmur, R., & İdiman, F. (2003) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(02)00127-0 · Cited by 37 · cited 4×
“However, a number of studies have also found decreased MEP amplitudes, prolonged MEP latencies, and increased MT in patients with MS [16,31,40,42–44, 46, 48, 49 , 51 , 54–56].”
BackgroundInfluentialCoates, K. D., Aboodarda, S. J., Krüger, R. L., Martin, T., Metz, L. M., Jarvis, S. E., & Millet, G. Y. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00165.2020 · Cited by 35 · cited 1×
“However, a number of studies have also found decreased MEP amplitudes, prolonged MEP latencies, and increased MT in patients with MS [16,31,40,42–44, 46, 48, 49 , 51 , 54–56].”
BackgroundInflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective
Bassi, M. S., Buttari, F., Gilio, L., Paolis, N. D., Fresegna, D., Centonze, D., & Iezzi, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00566 · Cited by 33
Salle, J., Hugon, J., Tabaraud, F., Boulesteix, J. M., Vallat, J., Dumas, M., & Poser, C. M. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90049-q · Cited by 32 · cited 1×
“A similar study by Salle et al. [65] monitored 23 MS patients who were treated with methylprednisolone, examining them at baseline, after treatment, and 2 months later.”
MethodMEP recruitment curves in multiple sclerosis and hereditary spastic paraplegia
Jørgensen, L. M., Nielsen, J. E., & Ravnborg, M. H. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.05.002 · Cited by 28
Imajo, Y., Kanchiku, T., Suzuki, H., Yoshida, Y., Funaba, M., Nishida, N., Fujimoto, K., & Taguchi, T. (2015) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2015.1117193 · Cited by 22
Manogaran, P., Vavasour, I. M., Borich, M. R., Kolind, S., Lange, A. P., Rauscher, A., Boyd, L. A., Li, D. K. B., & Traboulsee, A. L. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515579441 · Cited by 21 · cited 1×
“However, a number of studies have also found decreased MEP amplitudes, prolonged MEP latencies, and increased MT in patients with MS [16,31,40,42–44, 46, 48, 49 , 51 , 54–56].”
BackgroundTranscranial magnetic stimulation: Role in the evaluation of disability in multiple sclerosis
Sahota, P., Prabhakar, S. K., Lal, V., Khurana, D., Das, C., & Singh, P. (2005) · Neurology India · doi:10.4103/0028-3886.16409 · Cited by 19 · cited 3×
“A study by Sahota et al. [46] also examined a group of 30 MS patients, finding that patients after 3 months who improved clinically on the EDSS by one or more points from baseline had a statistically significant improvement in CMCT. Additionally, a recent study by Tremblay et al. [59] followed a…”
BackgroundResultA multiple regression model of normal central and peripheral motor conduction times
Jaiser, S. R., Barnes, J. D., Baker, S. N., & Baker, M. R. (2014) · Muscle & Nerve · doi:10.1002/mus.24427 · Cited by 18 · cited 1×
“A paper by Rossini et al. [13] reported that most studies have found no/weak Regarding height, there appears to be no correlation between height and CMCT for the upper limbs; however, there exists a strong correlation between height and CMCT for the lower limbs [22–24].”
BackgroundCortical Relay Time for Long Latency Reflexes in Patients with Definite Multiple Sclerosis
Tataroğlu, C., Genç, A., İdıman, E., Çakmur, R., & İdiman, F. (2004) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100120578 · Cited by 16
Neurophysiological outcomes following mesenchymal stem cell therapy in multiple sclerosis
Tremblay, F., Ansari, Y., Remaud, A., & Freedman, M. S. (2022) · Clinical Neurophysiology · doi:10.1016/j.clinph.2022.01.125 · Cited by 14 · cited 1×
“…on the EDSS by one or more points from baseline had a statistically significant improvement in CMCT. Additionally, a recent study by Tremblay et al. [59] followed a group of 20 MS patients over 48 weeks, where 9 of which were in the treatment group using mesenchymal stem cell (MSC) therapy as a…”
ResultRecommendations for the clinical use of motor evoked potentials in multiple sclerosis
Fernández, V., Valls‐Solé, J., Relova, J. L., Raguer, N., Miralles, F., Dinca, L., Taramundi, S., Costa‐Frossard, L., Ferrandiz, M., Ramió‐Torrentà, L., et al. (2013) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.09.003 · Cited by 11
Sapio, A. D., Bertolotto, A., Melillo, F., Sperli, F., Malucchi, S., & Troni, W. (2013) · Clinical Neurophysiology · doi:10.1016/j.clinph.2013.06.018 · Cited by 10
Tremor and Dysmetria in Multiple Sclerosis: A Neurophysiological Study
Alusi, S. H., Macerollo, A., MacKinnon, C. D., Rothwell, J. C., & Bain, P. G. (2021) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.598 · Cited by 10
The ipsilateral silent period: an early diagnostic marker of callosal disconnection in ALS
Hübers, A., Kassubek, J., Müller, H., Broc, N., Dreyhaupt, J., & Ludolph, A. C. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211044072 · Cited by 10 · cited 1×
“The iSP is thought to be mediated by transcallosal inhibitory neurons from the stimulated to the non-stimulated motor cortex, thereby suggesting that the iSP could reflect the functional integrity of the corpus callosum [6,28].”
BackgroundThe Use of Motor-Evoked Potentials in Clinical Trials in Multiple Sclerosis
Fernández, V. (2020) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000734 · Cited by 9
Intracortical motor conduction is associated with hand dexterity in progressive multiple sclerosis
Pisa, M., Chieffo, R., Congiu, M., Costa, G. D., Esposito, F., Romeo, M. A. L., Comola, M., Comı, G., & Leocani, L. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520960374 · Cited by 7
Transcranial cortical stimulation in disorders of the central motor pathways
Sue, C. M., Yiannikas, C., Clouston, P. D., Lim, C. L., & Graham, S. J. (1997) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(97)90005-9 · Cited by 6 · cited 1×
“However, a number of studies have also found decreased MEP amplitudes, prolonged MEP latencies, and increased MT in patients with MS [16,31,40,42–44, 46, 48, 49 , 51 , 54–56].”
BackgroundStutheit-Zhao, E. Y., Vavasour, I. M., Zakeri, M., Borich, M. R., Laule, C., Rauscher, A., Traboulsee, A. L., Li, D. K. B., Boyd, L. A., & MacKay, A. L. (2019) · Frontiers in Physics · doi:10.3389/fphy.2019.00141 · Cited by 4 · cited 1×
“…correlated with TMS-derived transcallosal inhibition (TCI; a brief suppression of voluntary activity in the primary motor cortex elicited by contralateral stimulation via the corpus callosum), which may suggest an association between structure and function in the context of MS demyelination [63].”
Cited by
Calderone, A., Latella, D., Fauci, E. L., Puleo, R., Sergi, A., Francesco, M. D., Mauro, M., Foti, A., Salemi, L., & Calabrò, R. S. (2025) · Biomedicines · doi:10.3390/biomedicines13092118 · Cited by 28
“Both single and repeated courses of TMS have been reported to enhance neuroplasticity, facilitating the reorganization of neural circuits and modulating neurotransmitter systems implicated in neurodegeneration [54,55].”
Long-chain n-3 polyunsaturated fatty acid supplementation and neuromuscular function in older adults
Hayman, O., Combet, E., Witard, O. C., & Gray, S. R. (2024) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000001065 · Cited by 8
Palantzas, A., & Anagnostouli, M. (2026) · Sensors · doi:10.3390/s26051738 · Cited by 1
“In multiple sclerosis (MS), TMS targeting motor, prefrontal, and cerebellar regions demonstrates improvements in spasticity, gait, fatigue, and cognitive function [116,117].”
Xue, Y., Chen, Y., Wang, F., Zhao, L., Li, T., Gong, A., Nan, W., & Fu, Y. (2025) · Cognitive Neurodynamics · doi:10.1007/s11571-025-10341-y · Cited by 2
Snow, N. J., Mohamed, B., Duraid, S., & Ploughman, M. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107035
Metadata
- Authors
- Sy, A., Thebault, S., Aviv, R. I., & Auriat, A. M.
- Affiliations
- University of Ottawa (CA)
- University of Pennsylvania (US)
- Corresponding author
- Auriat, Angela M.
- Venue
- Applied Sciences
- Publisher
- MDPI AG
- Published
- 2023-11-26
- Volume
- 13
- Issue
- 23
- Pages
- 12679
- ISSN
- 2076-3417 (ISSN-L)
- OpenAlex
- W4389049918
- Cited by
- 5
- References
- 67
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Applied Sciences (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Clinical Neurology › Peripheral Nerve Disorders
- Keywords
- transcranial magnetic stimulation, multiple sclerosis, motor evoked potentials, corticospinal tract integrity, motor cortex excitability, intracortical inhibition, intracortical facilitation, motor threshold, central motor conduction time, silent period, clinical disability, treatment monitoring, objective biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.